Type 2 diabetes mellitus (T2DM) management is complex and requires regular checkups, self-monitoring of blood glucose, dietary and lifestyle changes, and pharmacologic treatments to improve glycemic control and prevent comorbidities. For patients at high risk for atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), or chronic kidney disease (CKD), treatment guidelines recommend agents that reduce cardiorenal risk. This activity focuses on improving outcomes for T2DM patients with comorbidities. The Chair is joined by a Patient Advocate who speaks to the importance of shared decision-making and its role in improving treatment adherence and helping patients reach their treatment goals.
- Provider:Endocrine Society
- Activity Link: https://education.endocrine.org/URL/T2D_CEU24_Enduring
- Start Date: 2024-10-11 05:00:00
- End Date: 2024-10-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 141506.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism
Subscribe
Login
0 Comments
Oldest